Amanote Research
Register
Sign In
Tyrosine Kinase Inhibitor and Target Therapy
doi 10.2174/9781608057498113010011
Full Text
Open PDF
Abstract
Available in
full text
Date
July 24, 2013
Authors
Unknown
Publisher
BENTHAM SCIENCE PUBLISHERS
Related search
Steroid-Sparing Therapy for Tyrosine Kinase Inhibitor–Induced Pneumonitis
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Evaluation of a Tyrosine Kinase Peptide Microarray for Tyrosine Kinase Inhibitor Therapy Selection in Cancer
Experimental & Molecular Medicine
Managing Chronic Myeloid Leukemia Patients Intolerant to Tyrosine Kinase Inhibitor Therapy
Blood Cancer Journal
Oncology
Hematology
Stochastic Modelling of Tyrosine Kinase Inhibitor Rotation Therapy in Chronic Myeloid Leukaemia
BMC Cancer
Cancer Research
Oncology
Genetics
Tyrosine Kinase Inhibitor–Induced Pulmonary Arterial Hypertension
Advances in Pulmonary Hypertension
Cognitive Dysfunction After Withdrawal of Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukaemia
American Journal of Hematology
Hematology
Ibrutinib: The First Bruton's Tyrosine Kinase Inhibitor
Prescriber
Pharmacology
Targeting Tumour Microenvironment by Tyrosine Kinase Inhibitor
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Comparison of Tyrosine Kinase Inhibitor Versus Mammalian Target of Rapamycin Inhibitor as Second-Line Molecular-Targeted Therapy for Patients With Poor-Risk Metastatic Renal Cell Carcinoma
Anticancer Research
Medicine
Cancer Research
Oncology
